Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference95 articles.
1. Obara, W. et al. Present status and future perspective of peptide-based vaccine therapy for urological cancer. Cancer Sci. 109, 550–559 (2018).
2. Jiang, D., Niwa, M., Koong, A. C. & Diego, S. Cancer immunotherapy: moving forward with peptide T cell vaccines. Eur. J. Vasc. Endovasc. Surg. 49, 48–56 (2016).
3. Xia, A.-L., Wang, X.-C., Lu, Y.-J., Lu, X.-J. & Sun, B. Oncotarget chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities. Oncotarget 8, 90521–90531 (2017).
4. Finn, O. J. & Rammensee, H. G. Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Neoantigens: nothing new in spite of the name. Cold Spring Harb. Perspect. Biol. 10, a028829 (2018).
5. Hsiue, E. H. C. et al. Targeting a neoantigen derived from a common TP53 mutation. Science 371, eabc8697 (2021).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献